The Patent Finder

Terms ending in 2039

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,413,352Conjugate Based Systems for Controlled Insulin Delivery
In force
 · High confidence
Merck Sharp and Dohme LLCIn forceHigh confidence
US 11,498,904Novel Substituted Biaryl Compounds as Indoleamine 2,3-Dioxygenase (IDO) Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,111,297Antibodies Specific for Immunoglobulin-Like Transcript 3 (ILT3) and Uses Thereof
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,713,545Image Processing of Webpages
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,453,766RSV RNA Vaccines
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 12,234,265Stabilized RSV F Proteins and Uses Thereof
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,377,693System and Methods for Deriving Gene Signature Biomarkers of Response to PD-1 Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,695,928Rotary Rod Slicer
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,225,471Antidiabetic Bicyclic Compounds
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,311,528Oxo-Tetrahydro-Isoquinoline Carboxylic Acids as Sting Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
47 more term ends in 2039 · Pro
10 of 57 patents shown. Soonest term end first, then patent number.
Pro members see all 57.
Upgrade to Pro
50 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited